| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 1.07e-04 | 6 | 54 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.55e-04 | 51 | 54 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | E-box binding | 6.02e-04 | 61 | 54 | 3 | GO:0070888 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 6.40e-04 | 14 | 54 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | flippase activity | 9.51e-04 | 17 | 54 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.06e-03 | 74 | 54 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.32e-03 | 20 | 54 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 1.75e-03 | 23 | 54 | 2 | GO:0030215 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.59e-03 | 28 | 54 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 2.78e-03 | 29 | 54 | 2 | GO:0045499 | |
| Domain | ig | 2.18e-04 | 190 | 54 | 5 | PF00047 | |
| Domain | Immunoglobulin | 2.18e-04 | 190 | 54 | 5 | IPR013151 | |
| Domain | - | 5.94e-04 | 663 | 54 | 8 | 2.60.40.10 | |
| Domain | PDZ | 7.35e-04 | 141 | 54 | 4 | PF00595 | |
| Domain | PDZ | 8.80e-04 | 148 | 54 | 4 | SM00228 | |
| Domain | Ig-like_fold | 8.95e-04 | 706 | 54 | 8 | IPR013783 | |
| Domain | - | 9.25e-04 | 150 | 54 | 4 | 2.30.42.10 | |
| Domain | PDZ | 9.48e-04 | 151 | 54 | 4 | PS50106 | |
| Domain | Laminin_N | 9.59e-04 | 16 | 54 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 9.59e-04 | 16 | 54 | 2 | PS51117 | |
| Domain | Laminin_N | 9.59e-04 | 16 | 54 | 2 | PF00055 | |
| Domain | LamNT | 9.59e-04 | 16 | 54 | 2 | SM00136 | |
| Domain | PDZ | 9.72e-04 | 152 | 54 | 4 | IPR001478 | |
| Domain | fn3 | 1.23e-03 | 162 | 54 | 4 | PF00041 | |
| Domain | PUA-like_domain | 1.36e-03 | 19 | 54 | 2 | IPR015947 | |
| Domain | Semaphorin | 1.51e-03 | 20 | 54 | 2 | IPR027231 | |
| Domain | FN3 | 2.00e-03 | 185 | 54 | 4 | SM00060 | |
| Domain | FERM_C | 2.55e-03 | 26 | 54 | 2 | PF09380 | |
| Domain | FN3 | 2.61e-03 | 199 | 54 | 4 | PS50853 | |
| Domain | FERM_C | 2.75e-03 | 27 | 54 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 2.75e-03 | 27 | 54 | 2 | IPR018980 | |
| Domain | FN3_dom | 3.11e-03 | 209 | 54 | 4 | IPR003961 | |
| Domain | EGF_LAM_2 | 3.39e-03 | 30 | 54 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 3.39e-03 | 30 | 54 | 2 | PS01248 | |
| Domain | Sema | 3.62e-03 | 31 | 54 | 2 | SM00630 | |
| Domain | Semap_dom | 3.62e-03 | 31 | 54 | 2 | IPR001627 | |
| Domain | Sema | 3.62e-03 | 31 | 54 | 2 | PF01403 | |
| Domain | SEMA | 3.62e-03 | 31 | 54 | 2 | PS51004 | |
| Domain | FERM_N | 4.09e-03 | 33 | 54 | 2 | PF09379 | |
| Domain | FERM_N | 4.09e-03 | 33 | 54 | 2 | IPR018979 | |
| Domain | Laminin_EGF | 4.59e-03 | 35 | 54 | 2 | PF00053 | |
| Domain | EGF_Lam | 4.59e-03 | 35 | 54 | 2 | SM00180 | |
| Domain | PTPc | 4.85e-03 | 36 | 54 | 2 | SM00194 | |
| Domain | LAM_G_DOMAIN | 5.40e-03 | 38 | 54 | 2 | PS50025 | |
| Domain | Laminin_EGF | 5.40e-03 | 38 | 54 | 2 | IPR002049 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.68e-03 | 39 | 54 | 2 | PS50055 | |
| Domain | Laminin_G_2 | 5.97e-03 | 40 | 54 | 2 | PF02210 | |
| Domain | PTPase_domain | 6.26e-03 | 41 | 54 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 6.26e-03 | 41 | 54 | 2 | PF00102 | |
| Domain | EGF_1 | 6.29e-03 | 255 | 54 | 4 | PS00022 | |
| Domain | PSI | 7.18e-03 | 44 | 54 | 2 | IPR016201 | |
| Domain | LamG | 7.18e-03 | 44 | 54 | 2 | SM00282 | |
| Domain | IG | 7.26e-03 | 421 | 54 | 5 | SM00409 | |
| Domain | Ig_sub | 7.26e-03 | 421 | 54 | 5 | IPR003599 | |
| Domain | PSI | 7.83e-03 | 46 | 54 | 2 | SM00423 | |
| Domain | FERM_M | 7.83e-03 | 46 | 54 | 2 | PF00373 | |
| Pubmed | 1.43e-06 | 52 | 55 | 4 | 26633812 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 19683737 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8633026 | ||
| Pubmed | Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer. | 2.46e-06 | 2 | 55 | 2 | 20124444 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 27653687 | ||
| Pubmed | Fgfr2 is required for the expansion of the early adrenocortical primordium. | 7.40e-06 | 24 | 55 | 3 | 26141512 | |
| Pubmed | 1.29e-05 | 90 | 55 | 4 | 31280863 | ||
| Pubmed | Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. | 1.63e-05 | 31 | 55 | 3 | 22076636 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SHROOM3 LMF1 PTPRG FRMPD2 PVR SEMA3B ANKIB1 PRKD1 UTRN ATP10A CLDN12 | 1.80e-05 | 1489 | 55 | 11 | 28611215 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 2.34e-05 | 544 | 55 | 7 | 28473536 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 33159073 | ||
| Pubmed | Dual functional activity of semaphorin 3B is required for positioning the anterior commissure. | 2.45e-05 | 5 | 55 | 2 | 16202709 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 23902858 | ||
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 27551152 | ||
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 27067057 | ||
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 27539848 | ||
| Pubmed | 3.63e-05 | 117 | 55 | 4 | 17145500 | ||
| Pubmed | Early developmental arrest of mammalian limbs lacking HoxA/HoxD gene function. | 3.67e-05 | 6 | 55 | 2 | 15973411 | |
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 36994104 | ||
| Pubmed | Expression of class 3 semaphorins and neuropilin receptors in the developing mouse tooth. | 3.67e-05 | 6 | 55 | 2 | 11231073 | |
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 17942483 | ||
| Pubmed | Semaphorins III and IV repel hippocampal axons via two distinct receptors. | 6.83e-05 | 8 | 55 | 2 | 9753685 | |
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 20006658 | ||
| Pubmed | Requirement for core 2 O-glycans for optimal resistance to helminth infection. | 6.83e-05 | 8 | 55 | 2 | 23555902 | |
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 32392463 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 11906695 | ||
| Pubmed | IL-17-producing γδ T cells switch migratory patterns between resting and activated states. | 6.83e-05 | 8 | 55 | 2 | 28580944 | |
| Pubmed | Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease. | 8.78e-05 | 9 | 55 | 2 | 26169940 | |
| Pubmed | 8.78e-05 | 9 | 55 | 2 | 32537491 | ||
| Pubmed | 8.78e-05 | 9 | 55 | 2 | 35069539 | ||
| Pubmed | 8.78e-05 | 9 | 55 | 2 | 31959883 | ||
| Pubmed | Progression of vertebrate limb development through SHH-mediated counteraction of GLI3. | 1.10e-04 | 10 | 55 | 2 | 12215652 | |
| Pubmed | PRMT5 is necessary to form distinct cartilage identities in the knee and long bone. | 1.10e-04 | 10 | 55 | 2 | 31442442 | |
| Pubmed | 1.10e-04 | 10 | 55 | 2 | 38636522 | ||
| Pubmed | 1.23e-04 | 709 | 55 | 7 | 22988430 | ||
| Pubmed | 1.29e-04 | 963 | 55 | 8 | 28671696 | ||
| Pubmed | Class 3 semaphorins negatively regulate dermal lymphatic network formation. | 1.34e-04 | 11 | 55 | 2 | 26319580 | |
| Pubmed | 1.34e-04 | 11 | 55 | 2 | 15469978 | ||
| Pubmed | Evidence for intrinsic development of olfactory structures in Pax-6 mutant mice. | 1.34e-04 | 11 | 55 | 2 | 11074448 | |
| Pubmed | 1.60e-04 | 12 | 55 | 2 | 19812329 | ||
| Pubmed | 1.60e-04 | 12 | 55 | 2 | 36399562 | ||
| Pubmed | 1.60e-04 | 12 | 55 | 2 | 23991118 | ||
| Pubmed | Dual role for LIM-homeodomain gene Lhx2 in the formation of the lateral olfactory tract. | 1.60e-04 | 12 | 55 | 2 | 17329426 | |
| Pubmed | Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons. | 1.89e-04 | 13 | 55 | 2 | 23534961 | |
| Pubmed | A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. | 1.89e-04 | 13 | 55 | 2 | 21079607 | |
| Pubmed | Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome. | 2.21e-04 | 14 | 55 | 2 | 27716507 | |
| Pubmed | Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. | 2.54e-04 | 15 | 55 | 2 | 24650916 | |
| Pubmed | Hoxd and Gli3 interactions modulate digit number in the amniote limb. | 2.54e-04 | 15 | 55 | 2 | 17714700 | |
| Pubmed | 2.90e-04 | 16 | 55 | 2 | 21795281 | ||
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 2.90e-04 | 16 | 55 | 2 | 18489001 | |
| Pubmed | Balance between BDNF and Semaphorins gates the innervation of the mammary gland. | 2.90e-04 | 16 | 55 | 2 | 30628891 | |
| Pubmed | Nipbl and mediator cooperatively regulate gene expression to control limb development. | 2.90e-04 | 16 | 55 | 2 | 25255084 | |
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 3.29e-04 | 17 | 55 | 2 | 17626059 | |
| Pubmed | 3.29e-04 | 17 | 55 | 2 | 15944189 | ||
| Pubmed | Geminin is required for Hox gene regulation to pattern the developing limb. | 3.29e-04 | 17 | 55 | 2 | 32450229 | |
| Pubmed | 3.46e-04 | 210 | 55 | 4 | 16537572 | ||
| Pubmed | 3.70e-04 | 18 | 55 | 2 | 20386744 | ||
| Pubmed | 3.70e-04 | 18 | 55 | 2 | 26302206 | ||
| Pubmed | 3.70e-04 | 18 | 55 | 2 | 23913046 | ||
| Pubmed | 4.13e-04 | 19 | 55 | 2 | 15051154 | ||
| Pubmed | VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. | 4.58e-04 | 20 | 55 | 2 | 21658587 | |
| Pubmed | 4.58e-04 | 20 | 55 | 2 | 21350214 | ||
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 5.06e-04 | 21 | 55 | 2 | 36240771 | |
| Pubmed | 5.56e-04 | 22 | 55 | 2 | 15030763 | ||
| Pubmed | 6.08e-04 | 23 | 55 | 2 | 16672333 | ||
| Pubmed | Generation of mice with functional inactivation of talpid3, a gene first identified in chicken. | 6.08e-04 | 23 | 55 | 2 | 21750036 | |
| Pubmed | 6.63e-04 | 24 | 55 | 2 | 23063659 | ||
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 6.63e-04 | 24 | 55 | 2 | 15869472 | |
| Pubmed | 6.63e-04 | 24 | 55 | 2 | 10892744 | ||
| Pubmed | 7.20e-04 | 25 | 55 | 2 | 25848055 | ||
| Pubmed | 7.39e-04 | 257 | 55 | 4 | 16335952 | ||
| Pubmed | 7.79e-04 | 26 | 55 | 2 | 19060336 | ||
| Pubmed | Redundant and dosage sensitive requirements for Fgf3 and Fgf10 in cardiovascular development. | 7.79e-04 | 26 | 55 | 2 | 21664901 | |
| Pubmed | 9.04e-04 | 28 | 55 | 2 | 18617019 | ||
| Pubmed | 9.04e-04 | 28 | 55 | 2 | 17126317 | ||
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 9.70e-04 | 29 | 55 | 2 | 12435358 | |
| Pubmed | 9.70e-04 | 29 | 55 | 2 | 26959361 | ||
| Pubmed | 1.06e-03 | 283 | 55 | 4 | 21903422 | ||
| Pubmed | 1.06e-03 | 126 | 55 | 3 | 16284245 | ||
| Pubmed | c-Jun is required for the specification of joint cell fates. | 1.11e-03 | 31 | 55 | 2 | 23475960 | |
| Pubmed | Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. | 1.26e-03 | 33 | 55 | 2 | 16618389 | |
| Pubmed | 1.26e-03 | 33 | 55 | 2 | 29950483 | ||
| Pubmed | 1.28e-03 | 1049 | 55 | 7 | 27880917 | ||
| Pubmed | 1.41e-03 | 35 | 55 | 2 | 23716698 | ||
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 1.49e-03 | 36 | 55 | 2 | 26053890 | |
| Pubmed | 1.58e-03 | 37 | 55 | 2 | 22465667 | ||
| Cytoband | 7p22.1 | 1.47e-03 | 47 | 55 | 2 | 7p22.1 | |
| Cytoband | 3p21.3 | 2.31e-03 | 59 | 55 | 2 | 3p21.3 | |
| GeneFamily | PDZ domain containing | 4.59e-04 | 152 | 43 | 4 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 5.57e-04 | 160 | 43 | 4 | 555 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.02e-03 | 20 | 43 | 2 | 736 | |
| GeneFamily | Immunoglobulin like domain containing | 1.12e-03 | 193 | 43 | 4 | 594 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-07 | 192 | 55 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.36e-07 | 192 | 55 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.40e-07 | 193 | 55 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.45e-07 | 194 | 55 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.49e-07 | 195 | 55 | 6 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-06 | 171 | 55 | 5 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-06 | 171 | 55 | 5 | 3a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-06 | 174 | 55 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 2.87e-06 | 180 | 55 | 5 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-06 | 180 | 55 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-06 | 180 | 55 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.19e-06 | 184 | 55 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-06 | 184 | 55 | 5 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.28e-06 | 185 | 55 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.28e-06 | 185 | 55 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.46e-06 | 187 | 55 | 5 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.46e-06 | 187 | 55 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.83e-06 | 191 | 55 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.93e-06 | 192 | 55 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.03e-06 | 193 | 55 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-06 | 194 | 55 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-06 | 194 | 55 | 5 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-06 | 194 | 55 | 5 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 4.24e-06 | 195 | 55 | 5 | c3280bb6219e2eff5e24ef45aa2d76479a562122 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-06 | 198 | 55 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-06 | 198 | 55 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.68e-06 | 199 | 55 | 5 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.68e-06 | 199 | 55 | 5 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.68e-06 | 199 | 55 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.68e-06 | 199 | 55 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.79e-06 | 200 | 55 | 5 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.79e-06 | 200 | 55 | 5 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.79e-06 | 200 | 55 | 5 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.79e-06 | 200 | 55 | 5 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.79e-06 | 200 | 55 | 5 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.79e-06 | 200 | 55 | 5 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.79e-06 | 200 | 55 | 5 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.79e-06 | 200 | 55 | 5 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.79e-06 | 200 | 55 | 5 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.79e-06 | 200 | 55 | 5 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 130 | 55 | 4 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.34e-05 | 158 | 55 | 4 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.67e-05 | 161 | 55 | 4 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 4.67e-05 | 161 | 55 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 168 | 55 | 4 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 168 | 55 | 4 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 5.64e-05 | 169 | 55 | 4 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-05 | 171 | 55 | 4 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 6.32e-05 | 174 | 55 | 4 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-05 | 174 | 55 | 4 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-05 | 174 | 55 | 4 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 6.32e-05 | 174 | 55 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.46e-05 | 175 | 55 | 4 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.46e-05 | 175 | 55 | 4 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-05 | 176 | 55 | 4 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 176 | 55 | 4 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 176 | 55 | 4 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 177 | 55 | 4 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-05 | 177 | 55 | 4 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 177 | 55 | 4 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.75e-05 | 177 | 55 | 4 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.75e-05 | 177 | 55 | 4 | 8c78f7de091f16e86e326a73c9f1429e0232821f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.75e-05 | 177 | 55 | 4 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.90e-05 | 178 | 55 | 4 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.90e-05 | 178 | 55 | 4 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.05e-05 | 179 | 55 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 7.21e-05 | 180 | 55 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.36e-05 | 181 | 55 | 4 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.36e-05 | 181 | 55 | 4 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 7.36e-05 | 181 | 55 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.36e-05 | 181 | 55 | 4 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.36e-05 | 181 | 55 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.36e-05 | 181 | 55 | 4 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 7.36e-05 | 181 | 55 | 4 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 7.52e-05 | 182 | 55 | 4 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.52e-05 | 182 | 55 | 4 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 182 | 55 | 4 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 182 | 55 | 4 | e3248d108b51c49ca2c978636e13017e23b53860 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 182 | 55 | 4 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.68e-05 | 183 | 55 | 4 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 7.68e-05 | 183 | 55 | 4 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 7.68e-05 | 183 | 55 | 4 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.85e-05 | 184 | 55 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.85e-05 | 184 | 55 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.85e-05 | 184 | 55 | 4 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.85e-05 | 184 | 55 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.85e-05 | 184 | 55 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.01e-05 | 185 | 55 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 8.01e-05 | 185 | 55 | 4 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 8.01e-05 | 185 | 55 | 4 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.18e-05 | 186 | 55 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 8.18e-05 | 186 | 55 | 4 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 8.35e-05 | 187 | 55 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 8.35e-05 | 187 | 55 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.35e-05 | 187 | 55 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 8.52e-05 | 188 | 55 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 188 | 55 | 4 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.52e-05 | 188 | 55 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 188 | 55 | 4 | 9db778c1d9e622a68337212296e3a1ed8f771fa5 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 8.52e-05 | 188 | 55 | 4 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 7.92e-06 | 197 | 55 | 6 | 3685_UP | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 8.39e-06 | 199 | 55 | 6 | 6492_UP | |
| Disease | xerostomia | 9.14e-05 | 8 | 54 | 2 | EFO_0009869 | |
| Disease | Coronavirus infectious disease (implicated_via_orthology) | 1.17e-04 | 9 | 54 | 2 | DOID:0080599 (implicated_via_orthology) | |
| Disease | gamma-glutamylglutamate measurement | 2.95e-04 | 14 | 54 | 2 | EFO_0021137 | |
| Disease | serum urea measurement | 4.52e-04 | 195 | 54 | 4 | EFO_0009795 | |
| Disease | age at first sexual intercourse measurement | 6.73e-04 | 383 | 54 | 5 | EFO_0009749 | |
| Disease | urate measurement, bone density | 9.14e-04 | 619 | 54 | 6 | EFO_0003923, EFO_0004531 | |
| Disease | depressive symptom measurement | 1.08e-03 | 426 | 54 | 5 | EFO_0007006 | |
| Disease | glomerular filtration rate, response to platinum based chemotherapy | 1.21e-03 | 28 | 54 | 2 | EFO_0004647, EFO_0005208 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 1.21e-03 | 28 | 54 | 2 | DOID:0050866 (is_implicated_in) | |
| Disease | thoracic aortic aneurysm | 1.38e-03 | 30 | 54 | 2 | EFO_0004282 | |
| Disease | Colorectal Neoplasms | 1.66e-03 | 277 | 54 | 4 | C0009404 | |
| Disease | Colorectal Carcinoma | 1.74e-03 | 702 | 54 | 6 | C0009402 | |
| Disease | body fat percentage | 1.97e-03 | 488 | 54 | 5 | EFO_0007800 | |
| Disease | Neuroblastoma | 3.37e-03 | 47 | 54 | 2 | C0027819 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SWSQPETIYHPPIMN | 366 | P23470 | |
| TVYPPPHQVFTWTQM | 126 | P13051 | |
| PATHWPLYAQLMPHS | 21 | Q75L30 | |
| ATPWPLEPQHYLSFM | 621 | Q63HQ2 | |
| SYPQQAPYWTHPQRM | 141 | P22455 | |
| SWRPGPDNHSPITMY | 616 | Q8IWV2 | |
| IPPQWQVSHEFPMNF | 351 | O75131 | |
| GQFGVPQPWYFFIMP | 476 | Q99758 | |
| VQMPTPPPSGYNAWD | 286 | Q9P2G1 | |
| YPPSNPYWTMQALLG | 1256 | O60312 | |
| SWMPHPPYVMQPTGA | 301 | Q6XE24 | |
| QYWPDPPDVMNHGGF | 756 | P26045 | |
| YSSGPMRPFAQHPWR | 831 | Q8IXQ6 | |
| FVKNVPMNHGVYTWP | 136 | P0C881 | |
| FVKNVPMNHGVYTWP | 136 | B2RC85 | |
| YRPPQPAWMFGDPHI | 4676 | Q99102 | |
| FPSPMLYAGPTEVQW | 481 | O95340 | |
| QKHYTPSENFIWGPP | 301 | Q5TC84 | |
| AAFMYPPNPWKEISH | 796 | Q15139 | |
| PYQCPMTFGPRGHHW | 191 | Q15306 | |
| PYFHGWLIGHPEMSP | 41 | P61296 | |
| MTLYWSAGFHVPPHQ | 111 | Q68DX3 | |
| SLMHFAITNPGWQPP | 556 | Q7Z3C6 | |
| WMPGSVPNHPKYDIS | 341 | O95395 | |
| THSPGMFSWFPILFP | 571 | O14744 | |
| GPYFPRGWNNFHTIM | 191 | P41597 | |
| GATPNPYLWFNGPTM | 56 | Q12951 | |
| FWQPLYSHPPSMHTY | 206 | P56749 | |
| MTTNAGPLHPYWPQH | 1 | Q15125 | |
| SPHPYWLPNFMDVFT | 346 | P16298 | |
| QWMVQPHFLGPSSYP | 51 | P15407 | |
| PNAYTMPPLWGSQIF | 161 | Q3SX64 | |
| VSSVMQPYPLVWGHY | 16 | Q9Y2I2 | |
| GYNWSTTMGPLPPFA | 276 | P15151 | |
| SFRWSPPMFPNGVIH | 4846 | O75445 | |
| SMWPEHYDPSQSPQL | 3171 | P46939 | |
| PFAHKEGPNYQWMPF | 386 | Q13275 | |
| HTFPQQRYWPMYHPS | 921 | Q96RN1 | |
| FWAFPMNPSGLYITH | 321 | O15466 | |
| WHQTADFGYVPNPKM | 341 | Q9HAT2 | |
| SQGMIGPPWHQSYHS | 181 | Q8TF72 | |
| TMAQPPVHDYVPVSW | 326 | Q8TCX5 | |
| HEPLGLPMESYQPWA | 266 | P31271 | |
| RGHYFWMLSPFSPPS | 1166 | Q92954 | |
| WNFLPPNLGRHYIAM | 236 | Q9C0E2 | |
| SGQYWPSVYHAMPSP | 56 | Q96P53 | |
| GFPLPQVFLVPYAMW | 251 | O15375 | |
| PMHQWVSYQGRVPYP | 361 | Q13214 | |
| YKMQHWQPVYPPPSH | 641 | Q5JSZ5 | |
| ENGYIHPVNLTWPFM | 141 | O43680 | |
| NPNMYQSPPQWVDHT | 381 | Q15650 | |
| RWPMYPTSQPSNHPV | 801 | Q5VUA4 | |
| QPLSHPSPVWMNYSY | 1101 | Q96J92 | |
| PPWMNSGPSESRPYH | 366 | Q15637 | |
| YTPPSIMPQKHWVYV | 286 | O15209 | |
| RYLPWLYHPPSAMQQ | 2386 | Q9P2D8 | |
| PMPNPVAYYLHHSPW | 246 | Q96S06 |